Incyte Genomics Inc (INCY) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for INCY. 13F holdings as of 2026-06-30.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Baker Bros. Advisors | 30,762,330 | $3.5B | INCREASED |
| Vanguard | 20,594,512 | $2.3B | INCREASED |
| BlackRock | 18,032,718 | $2.0B | DECREASED |
| Dodge & Cox | 11,957,326 | $1.4B | DECREASED |
| State Street | 9,722,336 | $1.1B | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Ramitpal K Basi (EVP, Human Resources) | TAX-W | 504 | $65K | 2026-08-25 |
| Pablo J Cagnoni (President, Global Head of R&D) | SELL | 10,801 | $1M | 2026-08-19 |
| Pablo J Cagnoni (President, Global Head of R&D) | SELL | 10,803 | $1M | 2026-08-12 |
| Patrick A Mayes (EVP & Chief Scientific Officer) | EXERCISE | 2,207 | $235K | 2026-08-05 |
| Patrick A Mayes (EVP & Chief Scientific Officer) | SELL | 2,207 | $274K | 2026-08-05 |
Full institutional holdings, insider history, and congressional trades for Incyte Genomics Inc on SentiSense.